What is the recommended ceftriaxone injection dose for a 12-year-old child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ceftriaxone Injection Dose for 12-Year-Old

For a 12-year-old child, the recommended ceftriaxone dose is 50-75 mg/kg/day, with a maximum daily dose of 2 grams for most infections, administered once daily or divided every 12 hours.

Standard Dosing by Indication

Most Common Infections (Pneumonia, Skin/Soft Tissue, UTI)

  • Dose: 50-75 mg/kg/day 1, 2, 3
  • Maximum: 2 grams/day 3
  • Frequency: Once daily OR divided every 12 hours 1, 3
  • Route: IV infusion over 30 minutes 3

Meningitis (Severe CNS Infection)

  • Initial dose: 100 mg/kg (not to exceed 4 grams) 3
  • Maintenance: 100 mg/kg/day (maximum 4 grams daily) 3
  • Frequency: Once daily OR divided every 12 hours 3
  • Duration: 7-14 days for bacterial meningitis 3

Acute Otitis Media

  • Single IM dose: 50 mg/kg (maximum 1 gram) 3

Practical Calculation Example

For a typical 12-year-old weighing approximately 40 kg:

Standard infections:

  • 50 mg/kg = 2000 mg (2 grams) once daily
  • 75 mg/kg = 3000 mg, but capped at 2 grams for non-meningitis infections 3

Meningitis:

  • 100 mg/kg = 4000 mg (4 grams) once daily 3

Key Clinical Considerations

Once Daily vs. Twice Daily Dosing

The evidence supports once-daily dosing as equally effective and more convenient 4, 5, 6. Recent pharmacokinetic data in children with meningitis suggests that 100 mg/kg once daily achieves better CSF penetration and earlier target attainment compared to divided dosing 7. For non-meningitis infections, once-daily administration at 50-75 mg/kg provides adequate coverage and simplifies administration 4, 5.

Administration Details

  • Infusion time: 30 minutes for standard pediatric patients 3
  • Rapid infusion: 10-minute infusions of doses ≥50 mg/kg have been shown safe and feasible in children up to 12 years 8, though the FDA label recommends 30 minutes
  • Concentration: 10-40 mg/mL for IV administration 3

Duration of Therapy

  • Most infections: 4-14 days depending on severity 3
  • Streptococcus pyogenes: Minimum 10 days 3
  • Meningitis: 7-14 days 3
  • Continue for at least 2 days after clinical improvement 3

Common Pitfalls to Avoid

  1. Do not exceed maximum doses: Even if weight-based calculation suggests higher, cap at 2 grams for standard infections and 4 grams for meningitis 3

  2. Avoid calcium-containing solutions: Never mix or co-administer with calcium-containing IV solutions due to precipitation risk 3

  3. Do not use in hyperbilirubinemic neonates: This is not relevant for a 12-year-old but important to note the contraindication exists for younger patients 2, 3

  4. Ensure adequate renal dosing: No adjustment needed for renal impairment in standard cases 3, but monitor in severe dysfunction

  5. Consider local resistance patterns: The dosing assumes susceptible organisms. For highly resistant pneumococcus (MIC ≥4 mg/L), ceftriaxone 100 mg/kg/day is preferred 1

Special Situations

Severe pneumonia with mechanical ventilation: Consider 2 g daily (or weight-based equivalent up to maximum) as higher doses may improve mortality in critically ill patients 9

Outpatient parenteral therapy: Once-daily dosing makes ceftriaxone particularly suitable for home IV therapy or ambulatory infusion centers 4, 5

Staphylococcus aureus coverage: Ceftriaxone alone is insufficient for MRSA; add vancomycin or clindamycin if suspected 1

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.